Article Details
Retrieved on: 2018-02-20 16:37:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Finally, <b>Renaissance Technologies</b> LLC grew its position in OHR Pharmaceutical by 33.2% in the fourth quarter. <b>Renaissance Technologies</b> LLC now owns 1,050,109 shares of the biotechnology company's stock worth $1,953,000 after buying an additional 261,700 shares during the last quarter.</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here